How CapeStart Accelerated a Regulatory Submissions Through GenAI-Enabled Literature Review

A leading biotech company, faced critical challenges in their regulatory submission process. They needed to conduct a comprehensive clinical literature review and create a Clinical Evaluation Report (CER) with limited time and resources. 

The biotech company turned to CapeStart, who provided a hybrid approach combining expert analysis with their GenAI-powered MadeAi™ platform for literature review. Check-out their results.